Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project-Reference-Cited by-同舟云学术

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project

Published:2017-02 Issue: Volume:72 Page:177-185
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Applebaum Mark A.^ORCID,Vaksman Zalman,Lee Sang Mee,Hungate Eric A.,Henderson Tara O.,London Wendy B.,Pinto Navin,Volchenboum Samuel L.,Park Julie R.,Naranjo Arlene,Hero Barbara,Pearson Andrew D.,Stranger Barbara E.,Cohn Susan L.,Diskin Sharon J.

Funder

William Guy Forbeck Research Foundation

St. Baldrick's Foundation

Little Heroes Cancer Research Fund

Children's Neuroblastoma Cancer Foundation

Neuroblastoma Children's Cancer Foundation

Super Jake Foundation, Matthew Bittker Foundation

Alex's Lemonade Stand Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project;Moroz;Eur J Cancer,2011

2. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma;Baker;N Engl J Med,2010

3. Advances in risk classification and treatment strategies for neuroblastoma;Pinto;J Clin Oncol,2015

4. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study;Laverdiere;J Natl Cancer Inst,2009

5. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment;Rubino;Int J Cancer,2003

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review;Cancer Epidemiology, Biomarkers & Prevention;2024-05-27

2. Inflammatory myofibroblastic tumor of the liver after adrenal neuroblastoma surgery: a case report;Discover Oncology;2024-05-18

3. Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study;JNCI: Journal of the National Cancer Institute;2024-03-09

4. Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review;Targeted Oncology;2024-02-24

5. Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia;Frontiers in Oncology;2024-01-08